Article Information
History
- August 5, 2020.
Article Versions
- Version 1 (August 4, 2020 - 06:13).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Muge Cevik1,2,*,
- Syed Arefinul Haque3,
- Jennifer Manne-Goehler4,
- Krutika Kuppalli5,
- Paul E. Sax4,6,
- Maimuna S. Majumder7 and
- Chloe Orkin8,9
- 1Division of Infection and Global Health Research, School of Medicine, University of St Andrews, United Kingdom
- 2NHS Lothian Infection Service, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, United Kingdom
- 3Network Science Institute, Northeastern University, Boston, Massachusetts, United States
- 4Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts, United States
- 5Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina, United States
- 6Harvard Medical School, Boston, Massachusetts, United States
- 7Boston Children’s Hospital, Harvard Medical School, Boston, MA, United States
- 8Blizzard Institute, Queen Mary University of London, London, United Kingdom
- 9Royal London Hospital, Barts Health NHS Trust, London, United Kingdom
- ↵*Author of correspondence:
Name: Dr Muge Cevik, Address: Division of Infection and Global Health Research, School of Medicine, University of St Andrews, Fife, KY16 9TF, Telephone number: +447732800814, Email address: mc349{at}st-andrews.ac.uk
Posted August 05, 2020.
Gender disparities in international COVID-19 clinical trial leadership
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos